High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease - a pragmatic prognostic index
Open Access
- 1 May 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (10) , 1272-1277
- https://doi.org/10.1038/bjc.1996.244
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.1994
- One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.Journal of Clinical Oncology, 1993
- High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease — A 6-year updateAnnals of Oncology, 1993
- High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patientsAnnals of Oncology, 1993
- Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.1993
- High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.Journal of Clinical Oncology, 1993
- TREATMENT OF PROGRESSIVE HODGKINS-DISEASE WITH INTENSIVE CHEMORADIOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION1989
- High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's diseaseBritish Journal of Cancer, 1989
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Reporting results of cancer treatmentCancer, 1981